Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Christopher Lewert v. Boiron Inc et al
Case Number:
2:11-cv-10803
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Auer Ryan PC
- Boodell & Domanskis
- Crowell & Moring
- Dechert LLP
- Freeman Mathis
- Levin Sedran
- Lynch Carpenter
- Manfred APC
- Orrick Herrington
- Reed Smith
- Siprut PC
- Westerman Law Corp.
- Wilson Turner
- Zimmerman Reed
Companies
Sectors & Industries:
-
October 14, 2015
Homeopathic Co. Says False Ad Suit Lacks Evidence
Homeopathic medicine maker Boiron Inc. told a California federal judge on Wednesday that the partially certified class action claiming the company's flu symptom remedy label is misleading should be tossed, given that the lead plaintiff hasn't offered any evidence that the packaging contains false representations.
-
November 07, 2014
Class Wins Partial Cert. In Flu Remedy Labeling Suit
A California federal judge has certified part of a class in a suit accusing Boiron Inc. of continuing to make false claims about its homeopathic flu remedy despite a prior settlement, turning aside the company's attacks on the plaintiff's credibility.
-
February 28, 2014
Boiron Ducks Class Cert. In Suit Over Flu Remedy Label
A California federal judge shut down class certification efforts Thursday in a suit arguing that a $12 million consumer settlement with homeopathic medicine maker Boiron Inc. failed to alleviate false advertising surrounding its Oscillococcinum flu symptom remedy, saying the lead plaintiff lacked credibility on a critical issue.
- ← Previous
- 1
- 2
- Next →